🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The prognosis of patients with "high-grade B cell lymphoma with cellular my...
Status
Active Not Recruiting
Location
BE-Antwerpen-ZNASTUIVENBERG
Start Date
2018-08-01
Trial ID
NCT03620578
Treatments Being Tested
This is a phase Ⅱ study of erythropoietin for management of anemia caused b...
Status
Completed
Location
Multiple Locations
Start Date
2012-09-01
Trial ID
NCT02890602
Treatments Being Tested
We now propose to investigate the combination of CHOP-Rituxan plus PEG-Filg...
Status
Completed
Location
Hospital Auxilio Mutuo Cancer Center
Start Date
2006-01
Trial ID
NCT01527422
Treatments Being Tested
This randomized phase II trial is studying two different combination chemot...
Status
Unknown
Location
Oncology center
Start Date
2016-06-01
Trial ID
NCT03188198
Treatments Being Tested
The purpose of this study is to establish the safety of rituximab plus cycl...
Status
Completed
Location
UNC Project, Lighthouse Trust
Start Date
2016-03
Trial ID
NCT02660710
Treatments Being Tested
The purpose of this study is to improve the overall survival of Mantle-Cell...
Status
Unknown
Location
University Hospital
Start Date
2004-07
Trial ID
NCT00946374
Treatments Being Tested
This is a Phase 1, randomized, open-label, 2-way crossover, pharmacokinetic...
Status
Unknown
Location
Multiple Locations
Start Date
2020-08-15
Trial ID
NCT04243434
Treatments Being Tested
This study aims to explore a new treatment approach for patients with treat...
Status
Recruiting
Location
The First Affiliated Hospital of Soochow University
Start Date
2025-10-24
Trial ID
NCT07372365
Treatments Being Tested
This is a multicenter, open-label, non-randomized, phase II clinical trial ...
Status
Active Not Recruiting
Location
BC Cancer Agency
Start Date
2021-03-01
Trial ID
NCT04566887
Treatments Being Tested
The purpose of this study is to determine the selected dose of aflibercept ...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2008-03
Trial ID
NCT00644124
Treatments Being Tested